Microsclerotherapy Treatment Market

Microsclerotherapy Treatment Market: Global Industry Analysis and Opportunity Assessment 2017-2027

Market Overview

The very thin and tiny veins that look like a spider web below the skin is known as spider veins or thread veins. Spider vein are also known as small varicose veins. They are caused because of the malfunctioning of the valves in the veins. The bloods gets backed up in the veins resulting into swelling.  Microsclerotherapy is one of the best technique to treat spider veins.  It involves injecting a substance called as sclerosant, which destroys the veins over a period of time and makes it disappear. The technique is most used on legs and other body parts and rare on face due to the minimal possibility of scarring. Normally the patients require about 2 to 6 session of treatment at 4 to 8 weeks of intervals, also depending upon the size of the veins.

Microsclerotherapy Treatment Market: Drivers & Restraints

Rising incidence of spider veins and varicose veins is one of the major driving factor that can influence the growth of the global microsclerotherapy market. Comparatively painless procedure, minimal invasion, highly effective, fewer post-operative complications, simple analgesic required during the procedure are the important factors that will propel the growth of the global market through 2027. The incidence of spider veins are more prevalent in aging population, therefore rise in geriatric population is another factor that can positively influence the global market. Furthermore, heredity, prevalence of unhealthy lifestyle, obesity are the factors that can influence the growth of the global microsclerotherapy market during the forecast period.

Higher cost of the treatment, lack of training for surgeons, other alternative procedures, are few of the major factors that can restrain the growth of the global microsclerotherapy treatment market during the forecast period.

Microsclerotherapy Treatment Market: Overview

Microsclerotherapy treatment market is expected to expand at a significant growth rate across regions. Major players in this segment are working on their research and development process to build advanced products such as improved and effective sclerosants, improved after care and support. Microsclerotherapy is a widespread and a well-established technique for spider veins and with various organizations working to raise and maintain the standards of the treatment the global market is expected to anticipate a higher growth rate. Rise in prevalence of spider veins and varicose vein is one of the major factor attributing to the growth of the market. Furthermore, it is estimated that about 50 to 55 percent of the women in United States suffer from one or other type of vein disease which is one of the major factor that can accelerate the growth of the microsclerotherapy market in North America.

Microsclerotherapy Treatment Market: Region-wise Outlook

A geographic condition regarding microsclerotherapy treatment market, it has been segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific and the Middle East & Africa.

North America is expected to dominate the global microsclerotherapy market which is then followed by Europe. Advance healthcare infrastructure, growing importance of aesthetics, continuous lifestyle associated changes, prevalence of spider vein, high disposable income etc. are few of the factors attributing the growth of the microsclerotherapy market in the North America. The Asia Pacific region is expected to register a highest growth rate during the forecast period due to increase in patient awareness and early treatments, increase in disposable income, improved technological advancement.

Microsclerotherapy Treatment Market: Key Players

Some of the prominent players operating in the global microsclerotherapy market are The Vein Clinic, STD Pharmaceutical Products, Covidien, Kreussler Pharma, VASCULAR SOLUTIONS, Medicetics, and Skin Care Clinic, Maryland Dermatology Laser, Skin, & Vein Institute, LLC, among others worldwide.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Argentina, Brazil, Mexico and Rest of Latin America)
  • Western Europe (Germany, France, Italy, U.K, Spain, Benelux, Rest of Western Europe)
  • Eastern Europe (Poland, ,Russia, Rest of Western Europe)
  • Asia Pacific (China, ASEAN, Australia & New Zealand, Rest of APEJ)
  • Japan
  • Middle East and Africa (GCC, S. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Microsclerotherapy Treatment Market: Segmentation

The global microsclerotherapy treatment market is classified on the basis of material type and end-user.

Based on material type, the global microsclerotherapy market is segmented into the following:

  • Sclerosants
  • Sodium Tetradecyl sulphate
  • Polidocanol
  • Chromated glycerin
  • Others
  • Micro-Needles
  • Graduated compression hosiery supports
  • Others surgical products

Based on End-User, the global microsclerotherapy market is segmented into the following:

  • Cosmetic and Skin Clinics
  • Hospitals
  • Cosmetic Training Institutes

Based on geography, the global microsclerotherapy market is segmented into following:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
  • Eastern Europe (Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa)

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Need specific information?

In the news

How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival

by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights

Our Clients

View Our Reports from Healthcare

View Reports


Microsclerotherapy Treatment Market